Aminosalicylates contain the compound 5-aminosalicylic acid, or 5-ASA, which helps reduce inflammation. These drugs are used to prevent relapses and maintain remission in mild-to-moderate ulcerative colitis.
The standard aminosalicylate drug is sulfazine (Azulfidine). This drug combines the 5-ASA drug mesalamine with sulfapyridine, a sulfa antibiotic. While sulfazine is cheap and effective, the sulfa component of the drug can cause unpleasant side effects, including...
Read moreI have had ulcerative colitis for years, and it began when I stopped smoking. I have read that there may be an association. I... Read more »
The Crohn's and Colitis Foundation of America (CCFA) hosted a web/tele-conference this past week called, Ulcerative Colitis - The A to Z of... Read more »
Melatonin is a naturally occurring hormone in the body that is produced by the pineal gland. It has been well known for its role in the... Read more »
See Part I of this series for more Q&A from Dr. Eisner The arthritis in my knee has been acting up lately. A rheumatologist... Read more »
Whether we realize it or not, treatment options for both Crohn's Disease (CD) and Ulcerative Colitis (UC) have come a long way in the past... Read more »
A patient with ulcerative colitis tells Dr. Paul Donohue that Remicade treatments have stopped his symptoms. Dr. Donohue responds with information on... Read more »
Source: Harvard Decision Guide
Prevention There is no way to prevent ulcerative colitis. However, some people are able to decrease the frequency of symptoms by avoiding certain... Read more »
Source: ADAM Encyclopedia
Treatment can help suppress the inflammatory response and manage symptoms. A treatment plan for ulcerative colitis includes:Diet and... Read more »
Source: ADAM Encyclopedia
Complications in the IntestineMalabsorption and Malnutrition. Malabsorption is the inability of the intestines to absorb nutrients. In IBD, this... Read more »
This is a study to assess the safety and effectiveness of Humira at inducing remission in patients with moderately to severely active ulcerative... Read more »